The future of the life sciences industry hinges on AI and automation, driving innovation in drug discovery and addressing ...

Explore why Recursion Pharmaceuticals' AI-driven drug discovery faces challenges in revenue growth, governance, and investor ...

Background Myelin oligodendrocyte glycoprotein antibody ... TC is supported by grant funding from NIH, NMSS, Massachusetts Life Sciences Center, Department of Defense, Novartis Pharmaceuticals ...

While the recent VAT imposition on independent schools in the UK is unlikely to affect most internationally mobile families, it has taken place against the a background of broader ... of the Spear's ...

Merck Life Science opened its formulation & technology centre in Turbhe, Navi Mumbai. As a key part of Merck’s global R&D network, this next-generation facility will serve as a hub for industry ...

Merck KGaA's stock remains a 'hold' due to its high valuation, trading at an earnings multiple of around 20 and a 4.5% free ...

Merck KGa A officials say that, ultimately, the SMARTfacturing transformation benefits its customers, patients, and the ...

Recursion Pharmaceuticals appointed former FDA principal deputy commissioner Namandjé Bumpus, PhD, and Elaine Sun, the COO and CFO of Mammoth Biosciences, to its board of directors. CAMP4 Therapeutics ...

The new images—of when the cosmos was a mere 380,000 years old—show the "first steps towards making the earliest stars and ...

New research by the Atacama Cosmology Telescope (ACT) collaboration has produced the clearest images yet of the universe’s ...

today announced that it has entered into a five-year global distribution and collaboration agreement (the "Agreement") with the Life Science business of Merck KGaA, Darmstadt, Germany, which ...

The life sciences industry is in a position to help humanity, perhaps more than ever, with the introduction of generative AI (GenAI). Lengthy drug development timelines and complex regulatory ...